Ignyta Ends 2012 with Oversubscribed, Expanded Series B Financing

Raises $6 million in equity and capital term loan to catalyze personalized medicine in autoimmune diseases

(PRWeb December 31, 2012)

Read the full story at http://www.prweb.com/releases/2012/12/prweb10280690.htm


Comments are closed.